levodopa has been researched along with beta-(4-fluorobenzoyl)propionic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haapalinna, A; Haaparanta, M; Marjamäki, P; Niemi, R; Rinne, J; Solin, O | 1 |
Kreis, K; Kuntner, C; Langer, O; Mairinger, S; Muchitsch, V; Stanek, J; Wanek, T; Wingelhofer, B | 1 |
2 other study(ies) available for levodopa and beta-(4-fluorobenzoyl)propionic acid
Article | Year |
---|---|
Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Central Nervous System Stimulants; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2004 |
Preloading with L-BPA, L-tyrosine and L-DOPA enhances the uptake of [
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Caco-2 Cells; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Humans; Levodopa; Mice; Neoplasms, Experimental; Phenylalanine; Propionates; Tyrosine; Up-Regulation | 2016 |